Deutsche Bank reiterates a 'Buy' rating for HCA Holdings, Inc. The report highlights a recovery in surgical trends, boosting Q4 EBITDA growth despite weaker inpatient medical trends. Initial ACA guidance is considered conservative, with potential for mid-year revisions. Key takeaways include volume/pricing metrics, 2014 guidance assumptions, and ACA commentary. Updated estimates reflect modest adjustments due to HITECH and ACA ramp. Valuation risks include PPACA implementation and payer mix changes.
doj/DataSet10/EFTA01452968.pdf
{"title":"Deutsche Bank Markets Research - HCA Holdings, Inc.","key_people":["Darren Lehrich","Joshua Kalenderian","Dana Nentin"],"document_date":"2014-02-04","document_type":"financial","key_locations":["United States"],"document_subtype":"Research Report","key_organizations":["Deutsche Bank","HCA Holdings, Inc."],"reference_numbers":["DB-SDNY-0110321","SDNY_GM_00256505","EFTA01452968"]}